Lifecome Biochemistry Co.,Ltd.

¥18.62As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002868Healthcare
Country China
PE (Fwd) •••
TSR 9Y CAGR (2.44%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.89
PE TTM —
TSR TTM (34.53%)
Mkt cap ¥2.894B
ROIC (2.65%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥24
26.53%
(58.85%)
Hold 4|7|6|6|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.43
0.46
0.47
0.47
31.56%
30.72%
26.18%
17.53%
Revenue¥M
329.8
326.5
341.0
333.5
8.30%
8.36%
9.81%
3.45%
Peers (US$433.8M)
Cap (US$)
PE
440.2M
212.0x
Capital
TTM
5Y
10Y
Leveragex
9.652
(0.018)
(0.019)
EBIT/Intx
0.752
0.130
0.166
Own earn%
55.13
(7.67)
(11.49)
Sh yield%
53.72
60.66
57.58
Owners
Insiders/Inst%
0.71
61.63
Short interest%
5.74
SBC / revenue%
1.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
5–10
$1 testx
—
Incr. ROIC%
1